184 related articles for article (PubMed ID: 24846322)
1. Downregulation of HIPK2 increases resistance of bladder cancer cell to cisplatin by regulating Wip1.
Lin J; Zhang Q; Lu Y; Xue W; Xu Y; Zhu Y; Hu X
PLoS One; 2014; 9(5):e98418. PubMed ID: 24846322
[TBL] [Abstract][Full Text] [Related]
2. WIP1, a homeostatic regulator of the DNA damage response, is targeted by HIPK2 for phosphorylation and degradation.
Choi DW; Na W; Kabir MH; Yi E; Kwon S; Yeom J; Ahn JW; Choi HH; Lee Y; Seo KW; Shin MK; Park SH; Yoo HY; Isono K; Koseki H; Kim ST; Lee C; Kwon YK; Choi CY
Mol Cell; 2013 Aug; 51(3):374-85. PubMed ID: 23871434
[TBL] [Abstract][Full Text] [Related]
3. Wee1 inhibition potentiates Wip1-dependent p53-negative tumor cell death during chemotherapy.
Clausse V; Goloudina AR; Uyanik B; Kochetkova EY; Richaud S; Fedorova OA; Hammann A; Bardou M; Barlev NA; Garrido C; Demidov ON
Cell Death Dis; 2016 Apr; 7(4):e2195. PubMed ID: 27077811
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of HIPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells.
Puca R; Nardinocchi L; Pistritto G; D'Orazi G
Gynecol Oncol; 2008 Jun; 109(3):403-10. PubMed ID: 18395248
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of homeodomain-interacting protein kinase-2 contributes to bladder cancer metastasis by regulating Wnt signaling.
Tan M; Gong H; Zeng Y; Tao L; Wang J; Jiang J; Xu D; Bao E; Qiu J; Liu Z
J Cell Biochem; 2014 Oct; 115(10):1762-7. PubMed ID: 24824041
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA UCA1 increases chemoresistance of bladder cancer cells by regulating Wnt signaling.
Fan Y; Shen B; Tan M; Mu X; Qin Y; Zhang F; Liu Y
FEBS J; 2014 Apr; 281(7):1750-8. PubMed ID: 24495014
[TBL] [Abstract][Full Text] [Related]
7. LncRNA MST1P2/miR-133b axis affects the chemoresistance of bladder cancer to cisplatin-based therapy via Sirt1/p53 signaling.
Chen J; Li Y; Li Z; Cao L
J Biochem Mol Toxicol; 2020 Apr; 34(4):e22452. PubMed ID: 32052927
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of HIF-1alpha activity by homeodomain-interacting protein kinase-2 correlates with sensitization of chemoresistant cells to undergo apoptosis.
Nardinocchi L; Puca R; Sacchi A; D'Orazi G
Mol Cancer; 2009 Jan; 8():1. PubMed ID: 19128456
[TBL] [Abstract][Full Text] [Related]
9. Deficient DNA damage signaling leads to chemoresistance to cisplatin in oral cancer.
Wang L; Mosel AJ; Oakley GG; Peng A
Mol Cancer Ther; 2012 Nov; 11(11):2401-9. PubMed ID: 22973056
[TBL] [Abstract][Full Text] [Related]
10. VEGF-C inhibition reverses resistance of bladder cancer cells to cisplatin via upregulating maspin.
Zhu H; Yun F; Shi X; Wang D
Mol Med Rep; 2015 Aug; 12(2):3163-9. PubMed ID: 25936422
[TBL] [Abstract][Full Text] [Related]
11. Wip1 sensitizes p53-negative tumors to apoptosis by regulating the Bax/Bcl-xL ratio.
Goloudina AR; Mazur SJ; Appella E; Garrido C; Demidov ON
Cell Cycle; 2012 May; 11(10):1883-7. PubMed ID: 22544321
[TBL] [Abstract][Full Text] [Related]
12. Increased wild-type p53-induced phosphatase 1 (Wip1 or PPM1D) expression correlated with downregulation of checkpoint kinase 2 in human gastric carcinoma.
Fuku T; Semba S; Yutori H; Yokozaki H
Pathol Int; 2007 Sep; 57(9):566-71. PubMed ID: 17685927
[TBL] [Abstract][Full Text] [Related]
13. Homeodomain-interacting protein kinase-2 activity and p53 phosphorylation are critical events for cisplatin-mediated apoptosis.
Di Stefano V; Rinaldo C; Sacchi A; Soddu S; D'Orazi G
Exp Cell Res; 2004 Feb; 293(2):311-20. PubMed ID: 14729469
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of the wip1 gene abrogates the p38 MAPK/p53/Wip1 pathway and silences p16 expression in human breast cancers.
Yu E; Ahn YS; Jang SJ; Kim MJ; Yoon HS; Gong G; Choi J
Breast Cancer Res Treat; 2007 Mar; 101(3):269-78. PubMed ID: 16897432
[TBL] [Abstract][Full Text] [Related]
15. Homeodomain-interacting protein kinase2 in human idiopathic pulmonary fibrosis.
Ricci A; Cherubini E; Ulivieri A; Lavra L; Sciacchitano S; Scozzi D; Mancini R; Ciliberto G; Bartolazzi A; Bruno P; Graziano P; Mariotta S
J Cell Physiol; 2013 Jan; 228(1):235-41. PubMed ID: 22689412
[TBL] [Abstract][Full Text] [Related]
16. The estrogen receptor alpha pathway induces oncogenic Wip1 phosphatase gene expression.
Han HS; Yu E; Song JY; Park JY; Jang SJ; Choi J
Mol Cancer Res; 2009 May; 7(5):713-23. PubMed ID: 19435816
[TBL] [Abstract][Full Text] [Related]
17. The Role of Pyruvate Dehydrogenase Kinase-4 (PDK4) in Bladder Cancer and Chemoresistance.
Woolbright BL; Choudhary D; Mikhalyuk A; Trammel C; Shanmugam S; Abbott E; Pilbeam CC; Taylor JA
Mol Cancer Ther; 2018 Sep; 17(9):2004-2012. PubMed ID: 29907593
[TBL] [Abstract][Full Text] [Related]
18. PRDX2 regulates stemness contributing to cisplatin resistance and metastasis in bladder cancer.
Li P; Wang W; Zhu B; Wang Y; Li J; Wang C; Wang C; Li Q
Environ Toxicol; 2024 May; 39(5):2869-2880. PubMed ID: 38294069
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of Wip1 Enhances Sensitivity to Radiation in HeLa Cells Through Activation of p38 MAPK.
Wang HY; Liu ZS; Qiu L; Guo J; Li YF; Zhang J; Wang TJ; Liu XD
Oncol Res; 2014; 22(4):225-233. PubMed ID: 26351212
[TBL] [Abstract][Full Text] [Related]
20. Forkhead Box R2 Knockdown Decreases Chemoresistance to Cisplatin via MYC Pathway in Bladder Cancer.
Li Y; Zu X; Hu X; Wang L; He W
Med Sci Monit; 2019 Nov; 25():8928-8939. PubMed ID: 31761897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]